[go: up one dir, main page]

MX9801664A - Formas zwitterionicas de trovafloxacina, procedimiento para su preparacion, composiciones que las contienen y uso de las mismas. - Google Patents

Formas zwitterionicas de trovafloxacina, procedimiento para su preparacion, composiciones que las contienen y uso de las mismas.

Info

Publication number
MX9801664A
MX9801664A MX9801664A MX9801664A MX9801664A MX 9801664 A MX9801664 A MX 9801664A MX 9801664 A MX9801664 A MX 9801664A MX 9801664 A MX9801664 A MX 9801664A MX 9801664 A MX9801664 A MX 9801664A
Authority
MX
Mexico
Prior art keywords
trovafloxacin
zwitterionic forms
methods
hygroscopic
pentahydrate
Prior art date
Application number
MX9801664A
Other languages
English (en)
Other versions
MXPA98001664A (es
Inventor
Douglas John Meldrum Allen
David Bruning Joseph
Timothy Norris
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX9801664A publication Critical patent/MX9801664A/es
Publication of MXPA98001664A publication Critical patent/MXPA98001664A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Processing Of Solid Wastes (AREA)
  • Physical Water Treatments (AREA)

Abstract

Una forma zwitterionica de trovafloxacina de formula (I): seleccionada de entre el grupo formado por sus polimorfos higroscopicos y pentahidrato cristalinos y los procedimientos para su preparacion; la invencion se refiere además a procedimientos de uso, y composiciones farmacéuticas que los comprenden, los compuestos de la invencion para el tratamiento de infecciones bacterianas en mamíferos.
MXPA/A/1998/001664A 1995-08-29 1998-02-27 Formas zwitterionicas de trovafloxacina, procedimiento para su preparacion, composiciones que las contienen y uso de las mismas MXPA98001664A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US297595P 1995-08-29 1995-08-29
US002975 1995-08-29
PCT/IB1996/000756 WO1997007800A1 (en) 1995-08-29 1996-07-29 Zwitterionic forms of trovafloxacin

Publications (2)

Publication Number Publication Date
MX9801664A true MX9801664A (es) 1998-08-30
MXPA98001664A MXPA98001664A (es) 1998-11-12

Family

ID=

Also Published As

Publication number Publication date
EP0850060A1 (en) 1998-07-01
AR003985A1 (es) 1998-09-30
CO4480739A1 (es) 1997-07-09
HRP960395A2 (en) 1998-06-30
KR100343909B1 (ko) 2003-04-10
AP636A (en) 1998-04-09
PE12598A1 (es) 1998-03-20
IL122651A0 (en) 1998-08-16
WO1997007800A1 (en) 1997-03-06
SK23898A3 (en) 1999-05-07
MA23966A1 (fr) 1997-04-01
NO980862L (no) 1998-02-27
YU48396A (sh) 1998-12-23
OA10669A (en) 2000-11-06
CA2229786C (en) 2002-02-19
RU2144921C1 (ru) 2000-01-27
CZ56698A3 (cs) 1999-02-17
CN1190889A (zh) 1998-08-19
AP9600853A0 (en) 1996-10-31
HRP960395B1 (en) 2001-12-31
ZA967282B (en) 1998-03-02
JP3188476B2 (ja) 2001-07-16
NZ312199A (en) 1999-06-29
BR9609998A (pt) 1999-07-06
HUP9900170A2 (hu) 1999-05-28
AU704115B2 (en) 1999-04-15
GT199600072A (es) 1998-02-14
KR19990044232A (ko) 1999-06-25
DZ2087A1 (fr) 2002-07-22
PL325170A1 (en) 1998-07-06
TR199800339T1 (xx) 1998-06-22
NO309814B1 (no) 2001-04-02
TNSN96109A1 (fr) 2005-03-15
IL122651A (en) 2000-02-17
CA2229786A1 (en) 1997-03-06
JPH10511692A (ja) 1998-11-10
AU6367696A (en) 1997-03-19
MY113874A (en) 2002-06-29
HUP9900170A3 (en) 1999-11-29
NO980862D0 (no) 1998-02-27

Similar Documents

Publication Publication Date Title
MY113733A (en) Salts of an anti-migraine indole derivative
UA70298A (uk) Похідні с-4"-заміщених макролідів, спосіб їх одержання, проміжні сполуки, фармацевтична композиція та спосіб лікування бактеріальної інфекції або протозойної інфекції
BG103945A (en) Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a
BG103292A (en) 6-0-substituted ketolides possessing antibacterial effect
DE69831868D1 (en) Antithrombosemittel
LU91145I9 (es)
AU7725596A (en) Antithrombotic diamines
EP1019045A4 (en) ANTITHROMBOTIC AGENTS
IL165715A0 (en) 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
AP9801253A0 (en) 9-Oxime erythromycin derivatives.
BG104640A (en) Novel erythromycin derivatives
AP2001002131A0 (en) Novel macrolide antibiotics.
MY122353A (en) 13-membered azalides and their use as antibiotic agents
MX9804046A (es) 6-0-metil eritromicina d y proceso para hacerla.
CA2280328A1 (en) C11 carbamates of macrolide antibacterials
EP1057828A3 (en) Trovafloxacin oral suspensions
EP1019047A4 (en) ANTITHROMBOTIC AGENTS
IL126625A0 (en) 6-o-substituted erythromycin compounds and method for making same
CA2229786A1 (en) Zwitterionic forms of trovafloxacin
CA2301590A1 (en) 2-aminopyridines as inhibitors of cyclooxygenase-2
EP1027051A4 (en) ANTITHROMBOTIC AGENTS
AP2002002494A0 (en) Hygromycin derivatives.
MY118946A (en) Novel intermediates and their use to prepare n, n''- bridged bisindolylmaleimides
UA48982C2 (uk) Поліморфи проліків тровафлоксацину, спосіб їх отримання, спосіб лікування бактеріальної інфекції і фармацевтична композиція
DE69824410D1 (en) Antithrombosemittel

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees